Advertisement

Coffee and tea breaks for liver health

  • Salvatore Petta
    Correspondence
    Corresponding author. Address: Section of Gastroenterology and Hepatology, Di.Bi.M.I.S., University of Palermo, Italy, Piazza delle Cliniche, 2, 90127 Palermo, Italy. Tel.: +39 091 655 2170; fax +39 091 655 2156.
    Affiliations
    Section of Gastroenterology and Hepatology, Di.Bi.M.I.S., University of Palermo, Italy
    Search for articles by this author
  • Giulio Marchesini
    Affiliations
    Department of Medical and Surgical Sciences (DIMEC), “Alma Mater” University, Bologna, Italy
    Search for articles by this author
      Let food be your medicine (Hippocrates, ≈400 B. C.)

      Linked Article

      • Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: The Rotterdam study
        Journal of HepatologyVol. 67Issue 2
        • Preview
          Chronic liver diseases constitute a major public health problem. Liver cirrhosis was the 12th cause of death worldwide and the sixth cause of life-years lost in the adult population in developed countries in 2010.1,2 Chronic liver diseases are often silent for over 20 years until cirrhosis develops. Indeed, several studies have suggested that liver fibrosis may be present within unselected individuals. Using transient elastography (TE) as a diagnostic tool for liver fibrosis, a prevalence of 6–7% was found in the general population3,4 and even up to 17% in those high-risk populations with metabolic syndrome and type 2 diabetes.
        • Full-Text
        • PDF
      • Corrigendum to “Coffee and tea breaks for liver health” [J Hepatol 67 (2017) 221–223]
        Journal of HepatologyVol. 67Issue 5
        • Preview
          It has come to our attention that the authors name of the original article “Coffee and Herbal Tea Consumption is associated with lower Liver Stiffness in the General Population: The Rotterdam Study” in which this editorial refers to was misspelt in the Editorial. The correct spelling of the author is Alferink. We apologise for this error and the inconvenience caused.
        • Full-Text
        • PDF
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Birerdinc A.
        • Stepanova M.
        • Pawloski L.
        • Younossi Z.M.
        Caffeine is protective in patients with non-alcoholic fatty liver disease.
        Aliment Pharmacol Ther. 2012; 35: 76-82
        • Setiawan V.W.
        • Porcel J.
        • Wei P.
        • Stram D.O.
        • Noureddin N.
        • Lu S.C.
        • et al.
        Coffee drinking and alcoholic and nonalcoholic fatty liver diseases and viral hepatitis in the multiethnic cohort.
        Clin Gastroenterol Hepatol. 2017; https://doi.org/10.1016/j.cgh.2017.02.038
        • Gutierrez-Grobe Y.
        • Chavez-Tapia N.
        • Sanchez-Valle V.
        • Gavilanes-Espinar J.G.
        • Ponciano-Rodriguez G.
        • Uribe M.
        • et al.
        High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.
        Ann Hepatol. 2012; 11: 350-355
        • Zelber-Sagi S.
        • Salomone F.
        • Webb M.
        • Lotan R.
        • Yeshua H.
        • Halpern Z.
        • et al.
        Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.
        Transl Res. 2015; 165: 428-436
        • Catalano D.
        • Martines G.F.
        • Tonzuso A.
        • Pirri C.
        • Trovato F.M.
        • Trovato G.M.
        Protective role of coffee in non-alcoholic fatty liver disease (NAFLD).
        Dig Dis Sci. 2010; 55: 3200-3206
        • Anty R.
        • Marjoux S.
        • Iannelli A.
        • Patouraux S.
        • Schneck A.S.
        • Bonnafous S.
        • et al.
        Regular coffee but not espresso drinking is protective against fibrosis in a cohort mainly composed of morbidly obese European women with NAFLD undergoing bariatric surgery.
        J Hepatol. 2012; 57: 1090-1096
        • Molloy J.W.
        • Calcagno C.J.
        • Williams C.D.
        • Jones F.J.
        • Torres D.M.
        • Harrison S.A.
        Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.
        Hepatology. 2012; 55: 429-436
        • Bambha K.
        • Wilson L.A.
        • Unalp A.
        • Loomba R.
        • Neuschwander-Tetri B.A.
        • Brunt E.M.
        • et al.
        Coffee consumption in NAFLD patients with lower insulin resistance is associated with lower risk of severe fibrosis.
        Liver Int. 2014; 34: 1250-1258
        • Khalaf N.
        • White D.
        • Kanwal F.
        • Ramsey D.
        • Mittal S.
        • Tavakoli-Tabasi S.
        • et al.
        Coffee and caffeine are associated with decreased risk of advanced hepatic fibrosis among patients with hepatitis C.
        Clin Gastroenterol Hepatol. 2015; 13: 1521-1531e3
        • Freedman N.D.
        • Everhart J.E.
        • Lindsay K.L.
        • Ghany M.G.
        • Curto T.M.
        • Shiffman M.L.
        • et al.
        Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.
        Hepatology. 2009; 50: 1360-1369
        • Costentin C.E.
        • Roudot-Thoraval F.
        • Zafrani E.S.
        • Medkour F.
        • Pawlotsky J.M.
        • Mallat A.
        • et al.
        Association of caffeine intake and histological features of chronic hepatitis C.
        J Hepatol. 2011; 54: 1123-1129
        • Hodge A.
        • Lim S.
        • Goh E.
        • Wong O.
        • Marsh P.
        • Knight V.
        • et al.
        Coffee intake is associated with a lower liver stiffness in patients with non-alcoholic fatty liver disease, hepatitis C, and hepatitis B.
        Nutrients. 2017; 9
        • Ong A.
        • Wong V.W.
        • Wong G.L.
        • Chan H.L.
        The effect of caffeine and alcohol consumption on liver fibrosis – a study of 1045 Asian hepatitis B patients using transient elastography.
        Liver Int. 2011; 31: 1047-1053
        • Liu F.
        • Wang X.
        • Wu G.
        • Chen L.
        • Hu P.
        • Ren H.
        • et al.
        Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-analysis.
        PLoS One. 2015; 10e0142457
        • Yu C.
        • Cao Q.
        • Chen P.
        • Yang S.
        • Deng M.
        • Wang Y.
        • et al.
        An updated dose-response meta-analysis of coffee consumption and liver cancer risk.
        Sci Rep. 2016; 6: 37488
        • Goh G.B.
        • Chow W.C.
        • Wang R.
        • Yuan J.M.
        • Koh W.P.
        Coffee, alcohol and other beverages in relation to cirrhosis mortality: the Singapore Chinese Health Study.
        Hepatology. 2014; 60: 661-669
        • Setiawan V.W.
        • Wilkens L.R.
        • Lu S.C.
        • Hernandez B.Y.
        • Le Marchand L.
        • Henderson B.E.
        Association of coffee intake with reduced incidence of liver cancer and death from chronic liver disease in the US multiethnic cohort.
        Gastroenterology. 2015; 148 ([Quiz e15]): 118-125
        • Ruhl C.E.
        • Everhart J.E.
        Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States.
        Gastroenterology. 2005; 129: 1928-1936
        • Bamia C.
        • Lagiou P.
        • Jenab M.
        • Trichopoulou A.
        • Fedirko V.
        • Aleksandrova K.
        • et al.
        Coffee, tea and decaffeinated coffee in relation to hepatocellular carcinoma in a European population: multicentre, prospective cohort study.
        Int J Cancer. 2015; 136: 1899-1908
        • Huang Y.Q.
        • Lu X.
        • Min H.
        • Wu Q.Q.
        • Shi X.T.
        • Bian K.Q.
        • et al.
        Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations.
        Nutrition. 2016; 32: 3-8
        • Alferink L.J.M.
        • Fittipaldi J.
        • Kiefte-de Jong J.C.
        • Taimr P.
        • Hansen B.E.
        • Metselaar H.J.
        • et al.
        Coffee and herbal tea consumption is associated with lower liver stiffness in the general population: the Rotterdam study.
        J Hepatol. 2017; 67: 339-348
        • Salomone F.
        • Galvano F.
        • Li Volti G.
        Molecular bases underlying the hepatoprotective effects of coffee.
        Nutrients. 2017; 9
        • Marventano S.
        • Salomone F.
        • Godos J.
        • Pluchinotta F.
        • Del Rio D.
        • Mistretta A.
        • et al.
        Coffee and tea consumption in relation with non-alcoholic fatty liver and metabolic syndrome: A systematic review and meta-analysis of observational studies.
        Clin Nutr. 2016; 35: 1269-1281